Pack Quinn R, Rodriguez-Escudero Juan Pablo, Thomas Randal J, Ades Philip A, West Colin P, Somers Virend K, Lopez-Jimenez Francisco
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, MN; Division of Cardiology, Department of Medicine, Baystate Medical Center, Springfield, MA.
Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, MN; Department of Medicine, Mount Sinai Medical Center, Miami, FL.
Mayo Clin Proc. 2014 Oct;89(10):1368-77. doi: 10.1016/j.mayocp.2014.04.033. Epub 2014 Sep 8.
To assess the prognostic impact of weight loss on clinical outcomes in patients with coronary artery disease (CAD).
We performed a systematic review and meta-analysis of the prognostic effects of weight loss in patients with CAD on a composite outcome of all-cause mortality, cardiovascular mortality, and major adverse cardiac events considering studies published between January 1, 1964, and August 8, 2013. We considered weight loss "intentional" when it occurred in the presence of programmed therapeutic lifestyle changes and "observational" when no such intervention was specified.
We searched 1218 abstracts, of which 12 studies with 14 cohorts met the inclusion criteria. A total of 35,335 patients (mean age, 64 years; 72% male; body mass index [BMI], 30; 3.2 years of follow-up) were included. Overall, weight loss was associated with a greater risk of the composite outcome (relative risk [RR], 1.30; 95% CI, 1.00-1.69; P=.05). However, heterogeneity was high (I(2)=90%) and was substantially explained by weight loss intentionality. Presumed intentional weight loss (4 cohorts) was associated with improved outcomes (RR, 0.67; 95% CI, 0.56-0.80; P<.001), whereas observational weight loss (10 cohorts) was associated with worsened outcomes (RR, 1.62; 95% CI, 1.26-2.08; P<.001; interaction P<.001).
Whereas observational weight loss is associated with increased adverse cardiovascular events, intentional weight loss is associated with lower clinical events. These results suggest that the underlying mechanism of weight loss (ie, intentional or unintentional) affects its impact on subsequent risk in persons with known CAD.
评估体重减轻对冠状动脉疾病(CAD)患者临床结局的预后影响。
我们对1964年1月1日至2013年8月8日发表的研究进行了系统评价和荟萃分析,以探讨CAD患者体重减轻对全因死亡率、心血管死亡率和主要不良心脏事件这一复合结局的预后影响。当体重减轻发生在有计划的治疗性生活方式改变的情况下,我们认为是“有意的”体重减轻;当未明确提及此类干预措施时,则认为是“观察性的”体重减轻。
我们检索了1218篇摘要,其中12项研究的14个队列符合纳入标准。共纳入35335例患者(平均年龄64岁;72%为男性;体重指数[BMI]为30;随访3.2年)。总体而言,体重减轻与复合结局风险增加相关(相对风险[RR]为1.30;95%置信区间[CI]为1.00 - 1.69;P = 0.05)。然而,异质性较高(I² = 90%),且很大程度上可由体重减轻的意向性来解释。推测的有意体重减轻(4个队列)与结局改善相关(RR为0.67;95% CI为0.56 - 0.80;P < 0.001),而观察性体重减轻(10个队列)与结局恶化相关(RR为1.62;95% CI为1.26 - 2.08;P < 0.001;交互作用P < 0.001)。
观察性体重减轻与不良心血管事件增加相关,而有意体重减轻与较低的临床事件相关。这些结果表明,体重减轻的潜在机制(即有意或无意)会影响其对已知CAD患者后续风险的影响。